"Welcome to Banner Children's at Desert formerly Cardon Children’s Medical Center. From the moment you enter our facility, you will notice that we are a little different. Our front entrance is marked by a soothing water wall, lifelike trees, park benches and street lamps. Everything we do here is to welcome your family and make you feel comfortable."

During the past decade, Banner Children's at Desert conducted 50 clinical trials. In the 10-year time frame, 50 clinical trials started and 14 clinical trials were completed, i.e. on average, 28% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 12 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Banner Children's at Desert" #1 sponsor was "National Cancer Institute (NCI)" with 30 trials, followed by "Children's Oncology Group" with 27 trials sponsored, "Banner Health" with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored and "LLS PedAL Initiative, LLC" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Banner Children's at Desert" #1 collaborator was "National Cancer Institute (NCI)" with 28 trials as a collaborator, "Children's Oncology Group" with 5 trials as a collaborator, "Banner University Medical Center" with 1 trials as a collaborator, "Phoenix Children's Hospital" with 1 trials as a collaborator and "SpringWorks Therapeutics, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Banner Children's at Desert" are "Recurrent Neuroblastoma" (14 trials), "Refractory Neuroblastoma" (14 trials), "Refractory Non-Hodgkin Lymphoma" (14 trials), "Recurrent Hepatoblastoma" (12 trials) and "Recurrent Langerhans Cell Histiocytosis" (12 trials). Many other conditions were trialed in "Banner Children's at Desert" in a lesser frequency.

Most popular intervention types in "Banner Children's at Desert" are "Drug" (51 trials), "Other" (37 trials), "Procedure" (29 trials), "Radiation" (20 trials) and "Biological" (17 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (22 trials), "Laboratory Biomarker Analysis" (22 trials), "Vincristine Sulfate" (21 trials), "Biospecimen Collection" (18 trials) and "Cytarabine" (16 trials). Other intervention names were less common.

The vast majority of trials in "Banner Children's at Desert" are 62 trials for "All" genders.

Currently, there are NaN active trials in "Banner Children's at Desert". undefined are not yet recruiting, 28 are recruiting, 26 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Banner Children's at Desert, 2 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Banner Children's at Desert, 0 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".